Literature DB >> 21851424

Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.

L Yang1, J Tao, X Tang, Y Wang, X He, G Xu, Y Ren, Y Tu.   

Abstract

BACKGROUND: It has become clear that the morbidity and mortality of patients with lupus and cardiovascular disease (CVD) have substantially increased. Therefore, we designed a retrospective case-control study to assess the prevalence of traditional and lupus-specific risk factors for CVD in Chinese systemic lupus erythematosus (SLE) patients.
OBJECTIVE: To identify the prevalence and correlation of conventional and lupus-specific risk factors for CVD in Chinese SLE patients.
METHODS: One hundred and thirty-nine patients with SLE were enrolled in the study. They were compared with 139 age and gender-matched controls, who had no history of SLE or CVD. Among 139 SLE patients, there were 38 with CVD. We compared them with 38 SLE patients without CVD, matching for disease duration and age. Data regarding classic and lupus-specific risk factors were assessed between the two groups.
RESULTS: Hypertension, serum creatinine and diabetes mellitus were more prevalent among SLE than the controls (P < 0.05). The patients with SLE were more likely to have elevated total, low-density lipoprotein cholesterol and triglyceride levels than the controls (P < 0.001). However, high-density lipoprotein levels in SLE patients were lower than that in controls (P = 0.019). After being compared with SLE patients without CVD, the patients with both SLE and CVD were more likely to have elevated serum creatinine, proteinuria, the presence of anti-Sm antibody and decreased complement 4 (C4) levels (P < 0.05). Moreover, the patients with both diseases were less likely to be treated with hydroxychloroquine (P < 0.05). In multivariable analysis, elevated serum creatinine, proteinuria, decreased C4 levels, the presence of anti-Sm antibody and the lack of using hydroxychloroquine were independent risk factors for CVD (P < 0.05).
CONCLUSIONS: We are able to identify some conventional and lupus-specific risk factors for CVD in Chinese SLE patients.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21851424     DOI: 10.1111/j.1468-3083.2011.04211.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Altered body composition and increased visceral adipose tissue in premenopausal and late postmenopausal patients with SLE.

Authors:  Zhaoxia Li; Jingjie Shang; Shan Zeng; Huixia Wu; Yi Zhou; Hao Xu
Journal:  Clin Rheumatol       Date:  2019-07-30       Impact factor: 2.980

Review 2.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

Review 3.  Cardiovascular disease in lupus: insights and updates.

Authors:  Jason S Knight; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

4.  Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases.

Authors:  Chun-Yu Lin; Chun-Hsin Wu; Chung-Yuan Hsu; Tien-Hsing Chen; Ming-Shyan Lin; Yu-Sheng Lin; Yu-Jih Su
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

Review 5.  Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.

Authors:  Dan Liu; Xiaodan Li; Yonggang Zhang; Joey Sum-Wing Kwong; Ling Li; Yiyi Zhang; Chang Xu; Qianrui Li; Xin Sun; Haoming Tian; Sheyu Li
Journal:  Drug Des Devel Ther       Date:  2018-06-11       Impact factor: 4.162

Review 6.  Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis.

Authors:  Emily Keyes; Madison Grinnell; Douglas Jacoby; Thomas Vazquez; DeAnna Diaz; Victoria P Werth; Kevin Jon Williams
Journal:  Int J Womens Dermatol       Date:  2021-09-09

Review 7.  Risk factors in cardiovascular disease in systemic lupus erythematosus.

Authors:  Nailú Angélica Sinicato; Priscila Aparecida da Silva Cardoso; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2013-02-01

8.  Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients.

Authors:  Peng Zhao; Jinlin Miao; Kui Zhang; Minghua Lv; Qing Han; Ping Zhu
Journal:  Med Sci Monit       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.